Skip to content

Ironwood Pharmaceuticals IRWD Intangible assets — net

Intangible assets — net at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×
P/S1.8×+1.4×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's intangible assets — net?
Ironwood Pharmaceuticals (IRWD) reported intangible assets — net of $1.84M in Q1 2026.
How has Ironwood Pharmaceuticals's intangible assets — net changed year-over-year?
Ironwood Pharmaceuticals's intangible assets — net decreased by 30.9% year-over-year, from $2.66M to $1.84M.
What is the long-term trend for Ironwood Pharmaceuticals's intangible assets — net?
Over 2 years (2023 to 2025), Ironwood Pharmaceuticals's intangible assets — net has grown at a -25.6% compound annual growth rate (CAGR), from $3.68M to $2.04M.